Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132630) titled 'AI-Assisted Ultrasound Diagnosis of Prostate Cancer' on Sept. 16.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Chongqing University Cancer Hospital
Condition:
Prostate Cancer
Intervention:
Gold Standard:Pathological diagnosis obtained from ultrasound-guided biopsy or surgical pathology
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-15
Target Sample Size: Target condition:300;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=339116
Published by HT Digit...